Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 12871

Winter Park, FL 32789


Study Summary:

A 52-week, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the effect of roflumilast 500 μg on exacerbation rate in subjects with chronic obstructive pulmonary disease (copd) treated with a fixed-dose combination of long-acting beta agonist and inhaled corticosteroid (laba/ics).


Qualified Participants Must:

• Have a diagnosis of Chronic Obstructive Pulmonary Disease (COPD).
• Be 40 years of age or older.
• Be a former smoker
• Be on Advair or Symbicort for 3 months prior to visit 1
• Have had 2 documented COPD exacerbations treated with antibiotics or steroids.


Qualified Participants May Receive:

All study related medication and care at no cost. Eligible participants will be compensated for time and travel.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.